The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Adenoma, Liver Cell

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Adenoma, Liver Cell


High impact information on Adenoma, Liver Cell


Chemical compound and disease context of Adenoma, Liver Cell


Biological context of Adenoma, Liver Cell


Anatomical context of Adenoma, Liver Cell


Gene context of Adenoma, Liver Cell


Analytical, diagnostic and therapeutic context of Adenoma, Liver Cell


  1. Chronic toxicity study of cyclohexanone in rats and mice. Lijinsky, W., Kovatch, R.M. J. Natl. Cancer Inst. (1986) [Pubmed]
  2. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Diwan, B.A., Rice, J.M., Nims, R.W., Lubet, R.A., Hu, H., Ward, J.M. Cancer Res. (1988) [Pubmed]
  3. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Zucman-Rossi, J., Jeannot, E., Nhieu, J.T., Scoazec, J.Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., Wendum, D., Chiche, L., Fabre, M., Mellottee, L., Laurent, C., Partensky, C., Castaing, D., Zafrani, E.S., Laurent-Puig, P., Balabaud, C., Bioulac-Sage, P. Hepatology (2006) [Pubmed]
  4. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Owens, L.V., Xu, L., Craven, R.J., Dent, G.A., Weiner, T.M., Kornberg, L., Liu, E.T., Cance, W.G. Cancer Res. (1995) [Pubmed]
  5. Conditional liver-specific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice. Manickan, E., Satoi, J., Wang, T.C., Liang, T.J. J. Biol. Chem. (2001) [Pubmed]
  6. Biology of hepatocellular neoplasia in the mouse. II. Sequential enzyme histochemical analysis of BALB/c mouse liver during safrole-induced carcinogenesis. Lipsky, M.M., Hinton, D.E., Klaunig, J.E., Goldblatt, P.J., Trump, B.F. J. Natl. Cancer Inst. (1981) [Pubmed]
  7. Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Tong, W.M., Cortes, U., Hande, M.P., Ohgaki, H., Cavalli, L.R., Lansdorp, P.M., Haddad, B.R., Wang, Z.Q. Cancer Res. (2002) [Pubmed]
  8. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine. Lee, G.H., Ooasa, T., Osanai, M. Cancer Res. (1998) [Pubmed]
  9. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Müllauer, L., Taper, H., Huber, W., Bursch, W., Schulte-Hermann, R. Hepatology (1997) [Pubmed]
  10. Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine. Hacker, H.J., Mtiro, H., Bannasch, P., Vesselinovitch, S.D. Cancer Res. (1991) [Pubmed]
  11. Marked synergism of dimethylnitrosamine carcinogenesis in rats exposed to cadmium. Wade, G.G., Mandel, R., Ryser, H.J. Cancer Res. (1987) [Pubmed]
  12. Cytological effects of sulfur and selenium purine analogues on two transplantable hepatomas and on normal renewing cells in mice. Melvin, J.B., Haight, T.H., Leduc, E.H. Cancer Res. (1984) [Pubmed]
  13. Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Whysner, J., Ross, P.M., Williams, G.M. Pharmacol. Ther. (1996) [Pubmed]
  14. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B. Diwan, B.A., Henneman, J.R., Rice, J.M., Nims, R.W. Carcinogenesis (1996) [Pubmed]
  15. Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Lehmann, U., Berg-Ribbe, I., Wingen, L.U., Brakensiek, K., Becker, T., Klempnauer, J., Schlegelberger, B., Kreipe, H., Flemming, P. Clin. Cancer Res. (2005) [Pubmed]
  16. Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma. Chen, Z.M., Crone, K.G., Watson, M.A., Pfeifer, J.D., Wang, H.L. Am. J. Surg. Pathol. (2005) [Pubmed]
  17. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. Toyosawa, K., Okimoto, K., Kobayashi, I., Kijima, K., Kikawa, E., Kohchi, M., Koujitani, T., Tanaka, K., Matsuoka, N. Toxicologic pathology. (2001) [Pubmed]
  18. Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis. Terracciano, L.M., Tornillo, L., Avoledo, P., Von Schweinitz, D., Kühne, T., Bruder, E. Arch. Pathol. Lab. Med. (2004) [Pubmed]
  19. Fallacies of the fine needle aspiration cytology of surgical lesions of liver. Roy, M., Bhattacharyya, A., Dasgupta, S., Sanyal, S. Journal of the Indian Medical Association. (1994) [Pubmed]
  20. Establishment and characterization of a nontumorigenic cell line derived from a human hepatocellular adenoma expressing hepatocyte-specific markers. Schleger, C., Heck, R., Niketeghad, F., Schirmacher, P., Radaeva, S., Oesch, F., Dienes, H.P., Bannasch, P., Steinberg, P. Exp. Cell Res. (1997) [Pubmed]
  21. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine. Weber, E., Bannasch, P. Carcinogenesis (1994) [Pubmed]
  22. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis. Gouysse, G., Frachon, S., Hervieu, V., Fiorentino, M., d'Errico, A., Dumortier, J., Boillot, O., Partensky, C., Grigioni, W.F., Scoazec, J.Y. J. Hepatol. (2004) [Pubmed]
  23. Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation. Lubbers, P.R., Ros, P.R., Goodman, Z.D., Ishak, K.G. AJR. American journal of roentgenology. (1987) [Pubmed]
  24. Overexpression of the peroxisome proliferator activated receptor alpha or the human c-Ha-ras transgene is not involved in tumorigenesis induced by di(2-ethylhexyl)phthalate in rasH2 mice. Toyosawa, K., Okugawa, K., Teranishi, Y., Tanaka, K., Matsuoka, N. Cancer Lett. (2003) [Pubmed]
  25. Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet. Steinberg, P., Hacker, H.J., Dienes, H.P., Oesch, F., Bannasch, P. Carcinogenesis (1991) [Pubmed]
  26. Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. Kimura, S., Kawabe, M., Yu, A., Morishima, H., Fernandez-Salguero, P., Hammons, G.J., Ward, J.M., Kadlubar, F.F., Gonzalez, F.J. Carcinogenesis (2003) [Pubmed]
  27. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Moser, G.J., Wolf, D.C., Goldsworthy, T.L. Toxicologic pathology. (1997) [Pubmed]
  28. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy. Kong, C.S., Appenzeller, M., Ferrell, L.D. Acta Cytol. (2000) [Pubmed]
  29. Alteration of protein kinase C isoform-specific expression during rat hepatocarcinogenesis after exposure to the peroxisome proliferator WY-14,643. Corton, J.C., Swanson, C., Miller, R.T., Cattley, R.C. Cancer Lett. (1999) [Pubmed]
  30. Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67. Grigioni, W.F., D'Errico, A., Bacci, F., Gaudio, M., Mazziotti, A., Gozzetti, G., Mancini, A.M. J. Pathol. (1989) [Pubmed]
  31. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine. Weber, E., Bannasch, P. Carcinogenesis (1994) [Pubmed]
  32. Perspective on the carcinogenic potential of phenytoin based on rodent tumor bioassays and human epidemiological data. Dethloff, L.A., Graziano, M.J., Goldenthal, E., Gough, A., de la Iglesia, F.A. Human & experimental toxicology. (1996) [Pubmed]
  33. Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. Pereira, M.A. Anticancer Res. (1995) [Pubmed]
WikiGenes - Universities